TherapeuticsMD, Inc. (TXMD) is a publicly traded Healthcare sector company. As of August 11, 2026, TXMD trades at $2.09 with a market cap of $23.96M and a P/E ratio of 104.95. TXMD moved +0.00% today. Year to date, TXMD is +26.99%; over the trailing twelve months it is +91.67%. Its 52-week range spans $0.70 to $2.95. Rallies surfaces TXMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for TXMD, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $2.09 |
| Market Cap | $23.96M |
| P/E Ratio | 104.95 |
| EPS | $0.02 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.95 |
| 52-Week Low | $0.70 |
| Volume | 13.96K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.35M |
| Net Income | $179.00K |
| Gross Margin | 0.00% |
TXMD analyst coverage data. Average price target: $0.00.